[ET Net News Agency, 21 May 2019] CSPC Pharmaceutical Group Limited (01093) said its
profit attributable to owners of the company was RMB951.83 million for the three months
ended 31 March 2019, a year-on-year increase of 28.83%. The earnings per share were
RMB15.26 cents. No dividend will be distributed.
The revenue was RMB5.49 billion, a year-on-year increase of 25.57%. The gross profit was
RMB3.84 billion, a year-on-year increase of 36.63%. (RC)